1. Introduction {#sec1}
===============

Free radicals are highly reactive substances produced continuously during metabolic processes. They participate mainly in physiological events such as the immune response, metabolism of unsaturated fatty acids, and inflammatory reaction. The balance between free radicals and antioxidants is disrupted in many diseases. This disruption may be attributed to a number of factors such as the inability of the cells to produce sufficient amounts of antioxidants, the nutritional deficiency of minerals or vitamins, and the excess production of reactive oxygen species \[[@B1]\]. Free radical excess results in impairment of DNA, enzymes, and membranes and induces changes in the activity of the immune system and in the structure of basic biopolymers which, in turn, may be related to mutagenesis and aging processes \[[@B2]\].

The involvement of oxidative stress in the pathogenesis of hepatic dysfunction in human \[[@B2]--[@B15]\] and animals \[[@B1], [@B16]--[@B25]\] has been investigated for many years. Some of the liver diseases were associated with an increase \[[@B21], [@B24], [@B26]\] or decrease \[[@B17], [@B22], [@B27]--[@B29]\] in antioxidant\'s contents. Usually hepatic antioxidants increase at the beginning of hepatic disease and decrease in severe hepatic injury. The advantages of measuring hepatic oxidative status in liver biopsy are that it helps in diagnosis of hepatic dysfunction, reflects the degree of deterioration in the liver tissues, and helps to determine the severity of hepatic injury, and, also, it aids in recommending antioxidant\'s therapy in patients that had a hepatic disease with derangement in hepatic antioxidant constituents. The main purpose of the current paper is to explore the value of liver biopsy as a tool for detection of hepatic oxidative stress. A focus was done on different types of free radicals, antioxidants, lipid peroxidation, and hepatic and blood oxidative status in hepatic dysfunction.

2. Free Radicals {#sec2}
================

2.1. Types of Free Radicals {#sec2.1}
---------------------------

Free radicals can be defined as molecules containing a single unpaired electron in atomic or molecular orbits. These molecules have an important role in the pathogenesis of tissue damage in various disorders \[[@B30]\], such as hepatic dysfunction, mastitis, kidney damage, inflammation, immune injury, and carcinogenesis \[[@B1]\]. The most important free radicals include superoxide anion (O~2~^•−^), hydroxyl radical (**^•^**OH), and hypochlorous acid (HOCL) \[[@B31]\]. HOCL is produced by the reaction of hydrogen peroxide (H~2~O~2~) with chloride ions and plays an important role in the leukocyte respiratory burst, which is involved in the host defense system \[[@B32]\]. Nitric oxide (NO**^•^**) acts as a free radical and as a biological mediator in biochemical reactions. Physiologically it is synthesized from L-arginine by NO synthase employing cofactor NADPH. In the host, NO**^•^** arises in some pathological situations, such as sepsis, stroke, myocardial depression, and inflammatory responses \[[@B33]\].

Superoxide anion induces important reducing reactions in biological materials via Fenton-like reactions, which are catalyzed by redox cycling metal ions, including iron, copper, chromium, and vanadium \[[@B34]\]. These metal ions have the ability to accept and donate single electrons, making them important catalysts of free radical reactions; the most widely distributed and most commonly studied transition metal ions are the cations iron and copper \[[@B31]\]. Superoxide anion reduces Fe^3+^ in metalloproteins such as ferritin. The reduction of protein bound iron is an important reaction in biological material, because if there is sufficient H~2~O~2~ available, a reaction between the resultant Fe^2+^ and H~2~O~2~ occurs and gives rise to the highly reactive **^•^**OH \[[@B32]\], and H~2~O~2~ traverses biological membranes and intracellularly targets phospholipids, carbohydrates, metalloproteins, and DNA and causes damage via Fenton\'s reaction \[[@B35]\].

2.2. Sources of Free Radicals {#sec2.2}
-----------------------------

Free radicals may be released in the liver as a subsequence to hepatic detoxification of drugs, chemicals, and toxic materials \[[@B36], [@B37]\]. The formation of oxygen free radicals may be physiological as in phagocytosis (superoxide and H~2~O~2~ are used by phagocytic cells to kill bacteria), a side effect of metabolic pathways, or may occur in pathological conditions due to toxic agents as in the case of ischemia, inflammation, and disease, or due to decreased antioxidant defenses \[[@B38]\].

Mitochondria are considered a major source for the production of O~2~^•−^ and H~2~O~2~; about 2-3% of consumed oxygen is constantly converted into reactive oxygen/reactive nitrogen species (ROS/RNS) in the mitochondria; hepatocytes contain many mitochondria and therefore generate excess ROS/RNS \[[@B31]\].

In many liver diseases, including the wide range of neonatal hepatitis, the tissue inflammatory infiltrates are likely to be responsible for the formation of O~2~^•−^, H~2~O~2~, ^•^OH, HOCL, and the highly cytotoxic monochloramine \[[@B39], [@B40]\]. In turn, the superoxide anion attracts further neutrophils to the inflammatory site by a chemotactic activity, causing an increase in tissue injury \[[@B41]\]. In addition, activated macrophages, Kupffer cells, and vascular endothelium can generate nitric oxide, which may react with superoxide generating peroxynitrite. The latter is responsible for the inhibition of mitochondrial respiration and DNA synthesis \[[@B42]\].

Liver damage due to iron (hemochromatosis) and copper overload is believed, at least partially, to derive from the catalytic activity of these metals in the Fenton reaction leading to the generation of ROS and increased lipid peroxidation with consequent abnormal mitochondrial function \[[@B43]--[@B45]\].

3. Antioxidants and Free Radicals {#sec3}
=================================

The cells contain a variety of antioxidant mechanisms that play a central role in the protection against reactive oxygen species \[[@B46], [@B47]\]. The antioxidant system consists of antioxidant enzymes (superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px)), glutathione, ancillary enzymes (glutathione reductase (GR), glutathione S-transferase, and glucose 6-phosphate dehydrogenase (G6PD)), metal-binding proteins (transferrin, ceruloplasmin, and albumin), vitamins (alpha-tocopherol, ascorbate, and beta-carotene), flavonoids, and urate \[[@B48]\].

Pathological free radical reactions do not necessarily cause cell and tissue damage, as antioxidants of cells and tissues are able to prevent free radical injury \[[@B36]\]. On the intracellular level, ROS formation and metabolism can be summarized as shown in [Figure 1](#fig1){ref-type="fig"}.

4. Hepatic Oxidative Stress and Lipid Peroxidation {#sec4}
==================================================

Oxidative stress results when reactive forms of oxygen are produced faster than they can be safely neutralized by antioxidant mechanisms \[[@B49]\] and/or from a decrease in antioxidant defense, which may lead to damage of biological macromolecules and disruption of normal metabolism and physiology \[[@B50]\]. This condition can contribute and/or lead to the onset of health disorders \[[@B38]\] and play a damaging role in a number of liver disorders, for example, in anoxic and reoxygenation injury during transplantation, activated phagocytes and xanthine oxidase formed during ischemia, catalyzing the formation of superoxide during reperfusion \[[@B39], [@B51]--[@B53]\].

Lipid peroxidation is implicated in the pathogenesis of several hepatic disorders in human \[[@B2], [@B26]\] and animals \[[@B18], [@B22]\]. Hepatic failure in cattle was associated with decreased antioxidant mechanisms inside the cells, which led to the increase in the reactive oxygen species, especially H~2~O~2~. The decrease in hepatic GSH-Px activity in severe fatty degeneration, for example, results in the increase of H~2~O~2~ \[[@B22]\], which can initiate free radical formation through Fenton\'s reaction. In addition, the decrease in hepatic vitamin E level, which is an important chain-breaking antioxidant, results in lipid peroxidation and failure to regenerate the ascorbic acid \[[@B17], [@B18]\]. Increased hepatic oxidative stress was also reported in cows suffering from glycogen degeneration \[[@B22]\], sawdust liver, and liver abscesses \[[@B19], [@B21]\]. The authors contended that the antioxidant defense was high in the case of sawdust liver, glycogen degeneration, and liver abscess, which indicated that the body can combat the increased free radical stress.

Liver abscesses in fattening steers occur mainly due to intensive feeding of highly concentrated rations. Consumption of a carbohydrate-rich diet stimulates G6PD expression in endothelial and parenchymal cells \[[@B16], [@B19]\]. Since G6PD supports reactive oxygen metabolism, the response may represent an antioxidant pathway in the hepatic cell populations that targets sinusoid born reactive oxygen species during infections \[[@B19], [@B21]\].

Underfeeding in cattle was reported to induce changes in the antioxidant systems in liver manifested by lowering hepatic G6PD and SOD activities. This results in depletion of antioxidant defense mechanisms and renders the hepatocytes more susceptible to the lethal effects of endogenous or exogenous peroxides, and it indicates that the generation of lipid peroxides in cattle in poor nutritional condition exceeds the antioxidant capacity of the liver cells, generating a situation of oxidative stress and peroxidation \[[@B20]\].

The leading mechanism of free radical toxicity is the peroxidation of membrane phospholipids, which is initiated by the formation of lipid peroxide or hydroperoxides, and peroxy radicals are formed in the presence of oxygen to start a chain reaction (propagation) \[[@B2], [@B54], [@B55]\]. Various pathogenic effects occur as the result of degradation of membrane lipids \[[@B31]\]. Chiefly, the hydroxyl radical and to a lesser extent the superoxide anion leads to peroxidation of membrane lipids thereby causing production of malondialdehyde (MDA) and 4-hydroxyalkenals (4HNE). These substances directly induce hepatocytes damage with generation of proinflammatory cytokines, activation of spindle cells, and fibrogenesis \[[@B56], [@B57]\] and may bind to various molecules, impairing their functions \[[@B5]\] and therefore lead to membrane damage, protein damage, enzyme dysfunction, and DNA or RNA damage \[[@B58]\]. It is well known that persistent oxidant stress causes mutative effects on cell DNA and increases fibroblastic activity, leading to cirrhosis and carcinoma. Many studies have shown that oxidative stress takes part in the pathogenesis of cholestasis by way of cytokines \[[@B8], [@B11]--[@B13]\] and lipid peroxidation \[[@B6]\].

The role of lipid peroxidation in liver fibrosis was assessed. Lipid peroxidation products in the form of MDA adduct were detected in areas of active fibrogenesis. It has been shown that lipid peroxidation products can stimulate fibrogenesis by inducing collagen gene expression, and detection and prevention of lipid peroxidation could be of major interest in preventing fibrosis and cirrhosis in this disease \[[@B9]\].

Increased lipid peroxidation may be caused by inflammation related to viral infection and decreased antioxidant levels. The lipid peroxides formed may be chemotactic for the neutrophils causing increased inflammation, which further drives oxidant-mediated injury in the liver \[[@B59]\]. Previous studies have demonstrated an increase in MDA levels and decrease of the antioxidant capacity in acute and chronic hepatitis \[[@B3], [@B4], [@B55]\]. Mitochondrial lipid peroxidation takes place at varying levels in liver disorders independent of etiology \[[@B44], [@B60]\]. Increased lipid, protein, and nucleic acid peroxidation in the blood and liver biopsy specimens from patients with chronic hepatitis has been demonstrated \[[@B7], [@B15], [@B26]\].

5. Oxidative Stress and Hepatic Dysfunction: Role of Liver Biopsy {#sec5}
=================================================================

5.1. Blood and Hepatic Oxidative Stress {#sec5.1}
---------------------------------------

Antioxidant status of blood does not reflect hepatic oxidative stress only, but their levels change in response to diseases in other organs. Studying the effect of hepatic dysfunction on blood oxidative status in cows revealed that hepatic glycogen degeneration, fatty degeneration, or liver abscesses had no effect on erythrocytic oxidative status, as indicated by the insignificant changes in erythrocytes GSH-Px and G6PD activities \[[@B21], [@B22]\]. Many studies had been performed on humans to determine the effect of hepatic dysfunction on erythrocytic oxidative status; some of these studies had reported no significant changes in erythrocytes GSH-Px activity in patients suffered from liver cirrhosis and alcoholic liver disease \[[@B61]--[@B63]\]. Other studies had demonstrated that a red cell GSH-Px activity significantly decreased in patients with chronic liver disease \[[@B64]--[@B66]\]. In addition, lower activities of erythrocytes GSH-Px and SOD activities have been reported in patients with acute hepatitis B \[[@B67]\]. The cause of such contradictory results may be related to the degree of hepatic dysfunction or the presence or absence of selenium deficiency. Significant decreases in plasma selenium level and erythrocytes GSH-Px had been reported in patients with chronic liver disease \[[@B64]\].

Increased oxidative stress had been reported in the liver of cattle with naturally occurring fatty liver \[[@B18], [@B22]\], with liver abscessation \[[@B21]\], and in animals on restricted feed intake \[[@B20]\], without significant changes in blood oxidative status; this means that hepatic disease may present without effect on blood oxidative status and also that detection of hepatic oxidative stress is best done through measuring oxidative stress markers in the hepatic tissues by means of liver biopsy.

5.2. Preparation of Liver Biopsy for Antioxidants Measurements {#sec5.2}
--------------------------------------------------------------

The principles for preparation of liver biopsy are that liver biopsy must be prepared directly after collection, otherwise stored at −80°C, liver biopsy must be washed twice in a cold saline or cold buffer before homogenization, blot dry, and then homogenized in a cold buffer at certain pH. After centrifugation, the supernatant is harvested and used to measure hepatic antioxidant enzyme activities, which can be performed using commercial test kits ([Table 1](#tab1){ref-type="table"}).

5.3. Liver Biopsy and Oxidative Stress {#sec5.3}
--------------------------------------

Oxygen free radicals might play a role in the pathogenesis of tissue damage in many pathological conditions and have been implicated in a variety of liver diseases. It, therefore, may participate in the pathogenesis of toxic liver diseases and other hepatic alterations \[[@B10]\]. Oxidative stress is a major pathogenetic event occurring in several liver disorders ranging from metabolic to proliferated ones and is a main cause of liver damage in ischemia/reperfusion during liver transplantation \[[@B14]\].

The involvement of oxidative stress in the pathogenesis of liver injury has been investigated for many years \[[@B2]--[@B4]\]. Some of these studies were conducted using liver biopsy in human \[[@B70], [@B71]\] and animals \[[@B24], [@B25]\]. But most of the studies in animals measured hepatic oxidative stress after slaughtering or euthanasia. Examples include measuring hepatic G6PD activity in chemically induced hepatocellular carcinoma in rat liver \[[@B72]\] and in liver of rat with macronodular cirrhosis induced by long-term thioacetamide administration \[[@B73]\]. In cattle, hepatic GSH-Px activity \[[@B22]\] and vitamin E \[[@B17], [@B18]\] were measured in cows suffering from severe fatty degeneration. In addition, hepatic GSH-Px and G6PD activities were determined in cows suffering from glycogen degeneration \[[@B22]\], sawdust liver, and liver abscesses \[[@B16], [@B19], [@B21]\]. Furthermore, hepatic G6PD and SOD activities were measured in cows with restricted feed intake \[[@B20]\].

Recently, liver biopsy was applied as a tool for detecting hepatic oxidative stress in cattle from the viewpoint of the status of hepatic antioxidant enzymes after injection of a potent hepatotoxic (DL-ethionine), data published in \[[@B24], [@B25]\]; the supernatant of liver homogenate was used to measure hepatic SOD, catalase \[[@B25]\], total glutathione level and glutathione reductase activity \[[@B24]\].

Many studies were performed to establish the importance of liver biopsy from the viewpoint of oxidative stress in a variety of liver disorders in human. Examples in human include the following oxidative stress-related parameters were investigated in liver biopsy from NAFLD patients and used to assay activities of CAT and GSH-Px \[[@B28]\]. Oxidative stress status in children with glycogen storage disease \[[@B74]\] and with cholestatic chronic liver disease \[[@B70]\] was investigated by measuring GSH-Px, SOD, and CAT activities in liver biopsy samples. Activities of SOD, CAT, and GSH-Px were measured in liver biopsy specimens from patients with various liver diseases, including chronic persistent hepatitis, chronic active hepatitis, nonalcoholic cirrhosis, alcoholic cirrhosis, and acute hepatitis \[[@B71]\].

Increased hepatic oxidative stress had also been detected in liver biopsy from patients with cirrhosis and hepatocellular carcinoma, shown by the decrease of GSH-Px activity, hepatic and blood glutathione (GSH) levels, along with an increase in the oxidized glutathione/glutathione ratio in cirrhotic \[[@B26], [@B27]\] and liver cancer tissues \[[@B29]\], which reflects a decrease in both the synthesize capacity of liver and the antioxidant defense.

It is clear from the above review of the literature that liver biopsy can be used for measuring oxidative status of the liver tissues and that significant changes were detected in different hepatic dysfunctions. Antioxidant activities in liver biopsy can be used to diagnose liver disease and as a prognostic factor for the liver disease under investigation.

6. Conclusion {#sec6}
=============

Most of the studies done in animals were concerned with studying the hepatic oxidative stress after slaughtering or euthanasia. Studying the hepatic oxidative status in liver biopsy is lacking in animals. In human medicine, a large number of studies were implemented to achieve this goal. Hepatic disease may present without significant effect on blood oxidative status. Consequently, the best way is to measure hepatic oxidants and antioxidants in liver biopsy, which reflects the actual status of the liver.
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###### 

Methods for preparation of liver biopsy implemented in different studies.

  Tissue preparation                                                  Buffer used                                                                         Homogenization                                                                                                                                                                                                                                                  Oxidative stress marker   Reference
  ------------------------------------------------------------------- ----------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- --------------------
                                                                      Tris-HCL (50 mM) pH 7.5                                                             The liver biopsy was homogenized in 20 volumes of cold buffer, and then the supernatant was harvested after centrifugation at 5000 g for 30 min at 4°C.                                                                                                         SOD, CAT and GSH          \[[@B24], [@B25]\]
                                                                      Chilled potassium chloride (1.17%)                                                  Liver biopsy was homogenized in chilled buffer. The homogenates were centrifuged at 800 g for 5 min at 4°C to separate the nuclear debris. The obtained supernatant was recentrifuged at 10,500 g for 20 min at 4°C to get the postmitochondrial supernatant.   SOD, CAT and MDA          \[[@B68]\]
  Liver biopsy samples were washed twice in cold 0.9% salt solution   Ice-cold PBS buffer (20 mM), pH 7.3 with 10 ml of 5 mM butylated hydroxyl toluene   The tissue was homogenized in 290 ml ice-cold buffer. Following this, the suspension was centrifuged and supernatant was fractioned for analysis.                                                                                                               LPO and AOP               \[[@B69]\]
                                                                      Tris-HCl (50 mM), pH 7.5, 5 mM EDTA, 1 nM dithiothreitol                            The tissue was homogenized in 5 ml/g cold buffer. The homogenate was centrifuged at 10,000 g for 15 minutes at 4°C. The supernatant was removed for assay.                                                                                                      GSH-Px                    \[[@B70]\]
                                                                      Potassium phosphate (0.05 M) and 0.1 mM EDTA, pH 7.8                                The tissue was homogenized in 200 *μ*L buffer and centrifuged at 15,000 g for 30 minutes at 4°C. The supernatant was used for analysis.                                                                                                                         SOD                       \[[@B70]\]
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